Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb 3;15(1):476.
doi: 10.4081/mrm.2020.476. eCollection 2020 Jan 28.

The role of phenotype on ventilation and exercise capacity in patients affected by COPD: a retrospective study

Affiliations

The role of phenotype on ventilation and exercise capacity in patients affected by COPD: a retrospective study

Rocco F Rinaldo et al. Multidiscip Respir Med. .

Abstract

Background: The idea of phenotype in chronic obstructive pulmonary disease (COPD) has evolved in the last decades, and the importance of peculiar treatment strategies has now been acknowledged. Although dyspnea and exercise limitation are hallmarks of COPD, this aspect has never been fully explored in literature in terms of disease phenotype. The aim of the present study was to explore the relevance of clinical COPD phenotypes on exercise ventilation and maximal capacity.

Methods: In this observational cohort retrospective study we analyzed the data of 50 COPD patients who underwent cardiopulmonary exercise test, categorized as emphysematous (n=29), and non-emphysematous (n=21) according to a previously validated model.

Results: We found a significant difference in terms of VE/VCO2 slope (median values 32.4 vs 28.0, p=0.015) and VE/VCO2 ratio at nadir (median values 37 vs. 33, p=0.004), which resulted higher in emphysematous patients, who also presented lower PETCO2 values (median values 32.6 vs 35.6, p=0.008). In a subgroup of 31 tests which met the maximality criteria, emphysematous patients presented a significantly lower work rate at peak (median value 51 vs 72% predicted, p=0.016), and showed a lower peak oxygen consumption, although at the limit of significance (median values of 63 vs 85 % predicted, p=0.051).

Conclusions: This study extends our knowledge about the characterization of the COPD phenotypical expression of disease, showing that patients affected by emphysema are more prone to ventilatory inefficiency during exercise, and that this is likely to be an important cause of their overall reduced exercise capacity.

Keywords: COPD; cardiopulmonary exercise test; emphysema; exercise capacity; phenotype; ventilation.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The Authors declare no conflict of interest.

Figures

Figure 1.
Figure 1.
Graphical representation of the median values of VE/VCO2 slope and intercept in the two groups during cardiopulmonary exercise test. VCO2, Carbon dioxide output; VE/VCO2 slope median values and interquartile range: emphysematous 32.4 (29.4-35.3), non-emphysematous 28.0 (26.1-33.2); p=0.015. VE/VCO2 intercept median values and interquartile range: emphysematous 6.3 (3.7-7.6), non-emphysematous 5.6 (4.2-6.4); p=0.536.
Figure 2.
Figure 2.
Graphical representation of PETCO2 in the two groups during cardiopulmonary exercise test. *p<0.05. PETCO2, end tidal pressure for carbon dioxide. Median values and interquartile range of PETCO2 at peak: emphysematous 33 (30-35), nonemphysematous 36 (34-41); p=0.012. No significant differences between PETCO2 at other time points at the Mann-Whitney Utest with Bonferroni adjustment for multiple measures.
Figure 3.
Figure 3.
Relationship between peak exercise capacity and the carbon dioxide equivalent at nadir during cardiopulmonary exercise test. VO2, oxygen consumption; VCO2, carbon dioxide output; VE, Ventilation. Spearman’s r= -0.658, p<0.01, 43% of the variation explained.

References

    1. Burrows B, Fletcher CM, Heard BE, Jones NL, Wootliff JS. The emphysematous and bronchial types of chronic airways obstruction. Lancet 1966;287:830–5. - PubMed
    1. Agustí A, Hogg JC. Update on the pathogenesis of chronic obstructive pulmonary disease. N Engl J Med 2019;381:1248-56. - PubMed
    1. Han MLK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, et al. Chronic obstructive pulmonary disease phenotypes: The future of COPD. Am J Respir Crit Care Med 2010;182: 598-604. - PMC - PubMed
    1. Lange P, Halpin DM, O’Donnell DE, Macnee W. Diagnosis, assessment, and phenotyping of COPD: beyond FEV1. Int J Chron Obstruct Pulmon Dis. 2016;11 Spec Iss:3-12. doi: 10.2147/COPD.S85976. - PMC - PubMed
    1. Miravitlles M, Vogelmeier C, Roche N, Halpin D, Cardoso J, Chuchalin AG, et al. A review of national guidelines for management of COPD in Europe. Eur Respir J 2016;47:625–37. - PMC - PubMed